These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26937828)

  • 1. Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis.
    Heimburg T; Chakrabarti A; Lancelot J; Marek M; Melesina J; Hauser AT; Shaik TB; Duclaud S; Robaa D; Erdmann F; Schmidt M; Romier C; Pierce RJ; Jung M; Sippl W
    J Med Chem; 2016 Mar; 59(6):2423-35. PubMed ID: 26937828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of Schistosomiasis.
    Bayer T; Chakrabarti A; Lancelot J; Shaik TB; Hausmann K; Melesina J; Schmidtkunz K; Marek M; Erdmann F; Schmidt M; Robaa D; Romier C; Pierce RJ; Jung M; Sippl W
    ChemMedChem; 2018 Aug; 13(15):1517-1529. PubMed ID: 29806110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis.
    Ghazy E; Heimburg T; Lancelot J; Zeyen P; Schmidtkunz K; Truhn A; Darwish S; Simoben CV; Shaik TB; Erdmann F; Schmidt M; Robaa D; Romier C; Jung M; Pierce R; Sippl W
    Eur J Med Chem; 2021 Dec; 225():113745. PubMed ID: 34392190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.
    Stenzel K; Chakrabarti A; Melesina J; Hansen FK; Lancelot J; Herkenhöhner S; Lungerich B; Marek M; Romier C; Pierce RJ; Sippl W; Jung M; Kurz T
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28639720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
    Stolfa DA; Marek M; Lancelot J; Hauser AT; Walter A; Leproult E; Melesina J; Rumpf T; Wurtz JM; Cavarelli J; Sippl W; Pierce RJ; Romier C; Jung M
    J Mol Biol; 2014 Oct; 426(20):3442-53. PubMed ID: 24657767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni.
    Marek M; Kannan S; Hauser AT; Moraes Mourão M; Caby S; Cura V; Stolfa DA; Schmidtkunz K; Lancelot J; Andrade L; Renaud JP; Oliveira G; Sippl W; Jung M; Cavarelli J; Pierce RJ; Romier C
    PLoS Pathog; 2013; 9(9):e1003645. PubMed ID: 24086136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
    Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
    Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing.
    Simoben CV; Robaa D; Chakrabarti A; Schmidtkunz K; Marek M; Lancelot J; Kannan S; Melesina J; Shaik TB; Pierce RJ; Romier C; Jung M; Sippl W
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation.
    Kannan S; Melesina J; Hauser AT; Chakrabarti A; Heimburg T; Schmidtkunz K; Walter A; Marek M; Pierce RJ; Romier C; Jung M; Sippl W
    J Chem Inf Model; 2014 Oct; 54(10):3005-19. PubMed ID: 25243797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Design, Synthesis, and Biological Evaluation of Triazole-Based smHDAC8 Inhibitors.
    Kalinin DV; Jana SK; Pfafenrot M; Chakrabarti A; Melesina J; Shaik TB; Lancelot J; Pierce RJ; Sippl W; Romier C; Jung M; Holl R
    ChemMedChem; 2020 Apr; 15(7):571-584. PubMed ID: 31816172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages.
    Noce B; Di Bello E; Zwergel C; Fioravanti R; Valente S; Rotili D; Masotti A; Salik Zeya Ansari M; Trisciuoglio D; Chakrabarti A; Romier C; Robaa D; Sippl W; Jung M; Häberli C; Keiser J; Mai A
    ChemMedChem; 2023 Feb; 18(3):e202200510. PubMed ID: 36250286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schistosoma mansoni receptor tyrosine kinases: towards new therapeutic targets].
    Vicogne J; Dissous C
    J Soc Biol; 2003; 197(4):367-73. PubMed ID: 15005518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development.
    Ziniel PD; Karumudi B; Barnard AH; Fisher EM; Thatcher GR; Podust LM; Williams DL
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004279. PubMed ID: 26713732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
    Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Phenotypical Characterization of
    Saccoccia F; Brindisi M; Gimmelli R; Relitti N; Guidi A; Saraswati AP; Cavella C; Brogi S; Chemi G; Butini S; Papoff G; Senger J; Herp D; Jung M; Campiani G; Gemma S; Ruberti G
    ACS Infect Dis; 2020 Jan; 6(1):100-113. PubMed ID: 31661956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Screening of Histone Deacetylase (HDAC) Inhibitors against Schistosoma mansoni.
    Hassan MM; Sedighi A; Olaoye OO; Häberli C; Merz A; Ramos-Morales E; de Araujo ED; Romier C; Jung M; Keiser J; Gunning PT
    ChemMedChem; 2022 Sep; 17(18):e202100622. PubMed ID: 35983937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antischistosomal Activity of Pyrido[1,2-a]benzimidazole Derivatives and Correlation with Inhibition of β-Hematin Formation.
    Okombo J; Singh K; Mayoka G; Ndubi F; Barnard L; Njogu PM; Njoroge M; Gibhard L; Brunschwig C; Vargas M; Keiser J; Egan TJ; Chibale K
    ACS Infect Dis; 2017 Jun; 3(6):411-420. PubMed ID: 28440625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Antischistosomal Leads Identified from in Vitro and in Vivo Screening of the Medicines for Malaria Venture Pathogen Box.
    Pasche V; Laleu B; Keiser J
    ACS Infect Dis; 2019 Jan; 5(1):102-110. PubMed ID: 30398059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme.
    Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E
    J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.
    Marek M; Oliveira G; Pierce RJ; Jung M; Sippl W; Romier C
    Future Med Chem; 2015; 7(6):783-800. PubMed ID: 25996070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.